Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus

被引:25
作者
Yamamoto, Masahiko [1 ]
Fujihara, Kazuya [1 ]
Ishizawa, Masahiro [1 ]
Osawa, Taeko [1 ]
Kaneko, Masanori [1 ]
Ishiguro, Hajime [1 ]
Matsubayashi, Yasuhiro [1 ]
Seida, Hiroyasu [1 ,2 ]
Yamanaka, Nauta [2 ]
Tanaka, Shiro [3 ]
Kodama, Satoru [1 ]
Hasebe, Hiruma [4 ]
Sone, Hirohito [1 ,2 ]
机构
[1] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, 1-757 Asahimachi, Niigata 9518510, Japan
[2] Japan Med Data Ctr Co Ltd, Tokyo, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Clin Biostat, Kyoto, Japan
[4] Niigata Univ, Dept Ophthalmol, Fac Med, Niigata, Japan
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 08期
基金
日本学术振兴会;
关键词
blood pressure; diabetic mellitus; hemoglobin A1c; pulse pressure; systolic blood pressure; vision-threatening treatment-required diabetic eye diseases; RISK-FACTORS; INTRAVITREAL BEVACIZUMAB; RETINOPATHY; PREVALENCE;
D O I
10.1161/JAHA.118.010627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Evidence of the role of systolic blood pressure (SBP) in development of severe diabetic retinopathy is not strong, although the adverse effect of low diastolic blood pressure has been a partial explanation. We assessed the predictive ability of incident severe diabetic retinopathy between pulse pressure (PP) which considers both SBP and diastolic blood pressure, compared with SBP. Methods and Results-Eligible patients (12 242, 83% men) aged 19 to 72 years from a nationwide claims database were analyzed for a median observational 4.8-year period. Severe diabetic retinopathy was defined as vision-threatening treatment-required diabetic eye diseases. Multivariate Cox regression analysis revealed that hazard ratios (95% CI) of treatment-required diabetic eye diseases for 1 increment of standard deviation and the top tertile compared with the bottom tertile were 1.39 (1.21-1.60) and 1.72 (1.17-2.51), respectively, for PP and 1.22 (1.05-1.41) and 1.43 (0.97-2.11), respectively, for SBP adjusted for age, sex, body mass index, hemoglobin A1c, fasting plasma glucose, lipids, and smoking status. In a model with SBP and PP simultaneously as covariates, the hazard ratios of only PP (hazard ratios [95% CI], 1.57 [1.26-1.96]) but not SBP (0.85 [0.68-1.07]) were statistically significant. Delong test revealed a significant difference in the area under the receiver operating characteristic curve between PP and SBP (area under the receiver operating characteristic curve [95% CI], 0.58 [0.54-0.63] versus 0.54 [0.50-0.59]; P=0.03). The strongest predictor remained as hemoglobin A1c (area under the receiver operating characteristic curve [95% CI], 0.80 [0.77-0.84]). Conclusions-After excluding the significant impact of glycemic control, PP in comparison with SBP is a better predictor of severe diabetic retinopathy, suggesting a role of diastolic blood pressure and arterial stiffness in pathology.
引用
收藏
页数:18
相关论文
共 20 条
[1]   Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy [J].
Avery, Robert L. ;
Pearlman, Joel ;
Pieramici, Dante J. ;
Rabena, Melvin D. ;
Castellarin, Alessandro A. ;
Nasir, Ma'an A. ;
Giust, Matthew J. ;
Wendel, Robert ;
Patel, Arun .
OPHTHALMOLOGY, 2006, 113 (10) :1695-1705
[2]  
Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P716, DOI [10.1111/j.1755-3768.2012.02542.x, 10.1111/j.1755-3768.2012.2542.x]
[3]   Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy [J].
Chen, Eric ;
Park, Carl H. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (06) :699-700
[4]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[5]   Impact of glucose tolerance status on the development of coronary artery disease among working-age men [J].
Fujihara, K. ;
Igarashi, R. ;
Yamamoto, M. ;
Ishizawa, M. ;
Matsubayasi, Y. ;
Matsunaga, S. ;
Kato, K. ;
Ito, C. ;
Koishi, M. ;
Yamanaka, N. ;
Kodama, S. ;
Sone, H. .
DIABETES & METABOLISM, 2017, 43 (03) :261-264
[6]   Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients [J].
Hammes, H. P. ;
Kerner, W. ;
Hofer, S. ;
Kordonouri, O. ;
Raile, K. ;
Holl, R. W. .
DIABETOLOGIA, 2011, 54 (08) :1977-1984
[7]   Random measurement error and regression dilution bias [J].
Hutcheon, Jennifer A. ;
Chiolero, Arnaud ;
Hanley, James A. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :1402-1406
[8]   HIGH BLOOD-PRESSURE AS RISK FACTOR IN DIABETIC-RETINOPATHY DEVELOPMENT IN NIDDM PATIENTS [J].
ISHIHARA, M ;
YUKIMURA, Y ;
AIZAWA, T ;
YAMADA, T ;
OHTO, K ;
YOSHIZAWA, K .
DIABETES CARE, 1987, 10 (01) :20-25
[9]   Differential associations of central and brachial blood pressure with carotid atherosclerosis and microvascular complications in patients with type 2 diabetes [J].
Jung, Chan-Hee ;
Jung, Sang-Hee ;
Kim, Kyu-Jin ;
Kim, Bo-Yeon ;
Kim, Chul-Hee ;
Kang, Sung-Koo ;
Mok, Ji-Oh .
BMC CARDIOVASCULAR DISORDERS, 2014, 14
[10]   Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage [J].
Kimura, Shinya ;
Sato, Toshihiko ;
Ikeda, Shunya ;
Noda, Mitsuhiko ;
Nakayama, Takeo .
JOURNAL OF EPIDEMIOLOGY, 2010, 20 (05) :413-419